CD24 and neoplasm: Of the eleven miRNAs that were differentially enriched in CD24+ EVs between women with malignant and benign lesions, three were found to be differentially enriched in CD24+ EVs between women with low-risk benign and high-risk benign lesions with Wald test FDR-corrected p-values less than 0.05 (Supplementary Fig. S4 A).